Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
09/2005
09/28/2005CN1675169A Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid
09/28/2005CN1673212A Interconnected medicine precursor of gabapentin and pregabalin and its medicinal use
09/27/2005US6949677 Carbocyclic carboxy, oxo amines such as N-Isopropyl-3-oxo-N-[4-(phenylamino)phenyl]butyramide, used as fuel additives or drying promoters for polymers
09/27/2005US6949663 Multilayer; anticoagulant
09/27/2005US6949658 Water solvent is substituted with a linear, branched, or cyclic alcohol having 3 or more carbon atoms; the acid is preferentially precipitated from the alcohol; addition of a base enables purification of the alpha amino amide
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005US6949516 Oligopeptides used as antiapoptosis agents
09/27/2005CA2120942C Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/22/2005US20050209465 By reacting with substituted acetylenes in the presence of a phosphine ligand and a base (K2CO3); used to make drugs
09/22/2005US20050209327 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines
09/22/2005US20050208015 Glycerol derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2558036A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/21/2005EP1577296A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their use
09/21/2005EP1577295A1 Process for preparing 2-oxo-1-pyrrolidine derivatives as intermediates
09/21/2005EP1577292A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/21/2005EP1577291A1 Phenylethanolamine derivatives as beta-2 agonists
09/21/2005EP1577289A1 Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005CN1671654A Gelling agents
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1219751C Industrial production of benzofloxamide
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946453 Such as 7-azido-6-demethyl-6-deoxy-4-dedimethylamino tetracycline; for treatment of arthritis, bone disorders (osteoporosis), and emphysema
09/15/2005WO2005085188A2 Compounds and methods for anti-tumor therapy
09/15/2005WO2005084658A1 Derivatives of actarit and their therapeutic use
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005US20050203313 Production process of aminomethyl group-containing benzamide compound
09/15/2005US20050203170 Chalcones substitued with amine or amino acid-derived amide, specifically (S)-2-amino-3-hydroxypropanoic acid (2-methoxy-5-[2-methyl-3-oxo-3-(3,4,5-trimethoxyphenyl)propenyl]phenyl)amide hydrochloride; use inhibiting tubulin polymerization; antitumor agents
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/14/2005EP1574495A1 Adamantane derivatives
09/14/2005EP1574494A1 Adamantane derivative
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/13/2005US6943269 Contrast media for angiography
09/13/2005US6943191 dihydroxy or diketoaromatic compounds; protein kinase inhibitors; antiproliferative activity
09/09/2005WO2005082860A1 Tetracyclines and their use as calpain inhibitors
09/08/2005US20050197401 Growth factor-binding compounds and methods of use
09/07/2005EP1569896A1 Tetrahydro-naphthalene derivatives
09/07/2005EP1569893A2 Amino substituted hydroxyphenyl benzophenone derivatives
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005US6939889 Quarternary ammonium compounds
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them
09/06/2005CA2067690C Amino acid derivatives
09/01/2005WO2005080316A2 Modulators of cannabinoid receptors
09/01/2005WO2005079541A2 Terephthalamide peptidomimetic compounds and methods
09/01/2005WO2003101941A3 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
09/01/2005US20050192465 Process for the preparation of iopamidol
09/01/2005US20050192354 Such as N-alpha-(cyanoacetyl)-L-histidine; dipeptides
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005US20050192231 Treating hepatitis with a cytoprotective agents such as benzyloxycarbonyl-valine-aspartic acid(methyl ester)-methyl fluoride or having leucine and isoleucine as replacements for valine; caspase enzyme inhibitors; fas antigen suppressors; neuroprotective agents; antiischemic agents; organ transplants
09/01/2005CA2556940A1 Modulator
09/01/2005CA2556447A1 Terephthalamide peptidomimetic compounds and methods
08/2005
08/31/2005EP1568686A1 n-alkylaminated secondary paraphenylendiamine, which is ortho- and/or meta-substituted, dying composition comprising this paraphenylendiamine, methods based on this composition and uses
08/31/2005EP1568683A2 Secondary, N-alkylaminated para-phenylenediamines, compositions for dyeing keratinic fibres containing them, processes using this compositions and uses thereof
08/31/2005EP1163212B1 Amide derivatives
08/31/2005CN1660783A Fluorescence compound of polyamide and its application in recognizing hypersensitive light signal of positive ions
08/30/2005US6936736 Vision defects; Parkinson's disease; Alzheimer's disease
08/25/2005WO2005077945A2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/25/2005WO2005077884A2 Hydroaminomethylation of olefins
08/25/2005WO2005077122A2 Compounds and compositions as lxr modulators
08/25/2005WO2005061437A3 Isopeptide gap junction modulators
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187198 Methods of preparing substituted tetracyclines with transition metal-based chemistries
08/25/2005US20050187167 Polyene polyketides, processes for their production and their use as a pharmaceutical
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/25/2005CA2555291A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/25/2005CA2553442A1 Compounds and compositions as lxr modulators
08/24/2005EP1566376A1 Preparation of amino acid amides
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659136A Novel sodium channel blockers
08/24/2005CN1659135A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia
08/24/2005CN1659134A Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom
08/23/2005US6933352 Amphiphilic compounds having a dendritic branch structure
08/23/2005US6933314 Integrin receptor inhibitors
08/18/2005WO2005075455A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005US20050182262 Reacting an amino acid or acid salt with a halogenating agent (thionyl chloride, phosphorous pentachloride or oxalyl chloride) , to form an intermediate, reacting the intermediate with ammonia; amidation; chemical intermediate to form Levetiracetam
08/18/2005US20050182040 Benzamide derivatives
08/18/2005CA2720312A1 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005CA2497062A1 Preparation of amino acid amides
08/17/2005EP1562575A1 Fused cycloalkyl amides and acids and their therapeutic applications for the treatment of i.a. epilepsy
08/17/2005CN1656065A Ligand as the RAR receptor inhibitor
08/17/2005CN1656058A Amide derivatives as inhibitors of the enzymatic activity of renin
08/17/2005CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
08/17/2005CN1656056A Production process of aminomethyl group-containing benzamide compound
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1215054C Microbicidal N-sulfonylglycin alkynyloxyphenemethyl amide derivatives
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 162